Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

Nature

Volumn 426, Issue 6966, 2003, Pages 574-579

  Lorenz, Kristina ^a   Lohse, Martin J ^a   Quitterer, Ursula ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CELLS; ENZYMES; PHYSIOLOGY;

PHOSPHORYLATION;

BIOCHEMISTRY;

G PROTEIN COUPLED RECEPTOR KINASE 2; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C; RAF PROTEIN;

BIOLOGY; PROTEIN;

ADAPTATION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPERTENSION; INTERNALIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANDROGEN-BINDING PROTEIN; ANIMALS; BETA-ADRENERGIC RECEPTOR KINASE; BRAIN; CARRIER PROTEINS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; HUMANS; MICE; MYOCYTES, CARDIAC; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; UTEROGLOBIN;

MAMMALIA;

EID: 0346874333     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02158     Document Type: Article

References (27)

1. Krupnick, J.G. #38; Benovic, J. L. The role of receptor kinases and arrestins in G piotein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38, 289-319 (1998).
2. Lefkowitz, R. J., Pitcher, J., Krueger, K. #38; Daaka, Y. Mechanisms of β-adrenergic receptor desensitization and resensitization. Adv. Pharmacol. 42, 416-420 (1998).
3. Jaber, M. et al. Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl Acad. Sci. USA 93, 12974-12979 (1996).
4. Gros, R., Benovic, J. L., Tan, C. M. #38; Feldman, R. D. G-protein-coupled receptor kinase activity is increased in hypertension. J. Clin. Invest. 99, 2087-2093 (1997).
5. 2-adrenergic receptors in the failing human heart. Circulation 87, 454-463 (1993).
6. Yeung, K. et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173-177 (1999).
7. Yeung, K. et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the rafkinase inhibitor protein. Mol. Cell. Biol. 20, 3079-3085 (2000).
8. Corbit, K. C. et al. Activation of Raf-1 signaling by protein kinase through a mechanism involving Raf kinase, inhibitory protein. J. Biol. Chem. 278, 13061-13068 (2003).
9. Slupsky, J. R. et al. Binding of Gβγ subunits to cRaf1 downregulates G-protein-coupled receptor signalling. Curr. Biol. 9, 971-974 (1999).
10. 1B-adrenergic receptor. J. Biol. Chem. 271, 5059-5058 (1996).
11. Dicker, F., Quitterer, U., Winstel, R., Honold, K. #38; Lohse, M. J. Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases. Proc. Natl Acad. Sci. USA 96, 5476-5481 (1999).
12. 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J. Biol. Chem. 265, 3202-3211 (1990).
13. Pitcher, J. A. et al. Role βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science 257, 1264-1267 (1992).
14. Krasel, C. et al. Phosphorylation of GRK2 by protein kinase C abolishes Its inhibition by calmodulin. J. Biol. Chem. 276, 1911-1915 (2001).
15. Eichmann, T. el al. The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gβγ binding site. J. Biol. Chem. 278, 8052-8057 (2003).
16. Yu, Q. M. et al. The amino terminus with a conserved glutamic acid of G protein-coupled receptor kinases is indispensable for their ability to phosphorylate photoactivated rhodopsin. J. Neurochem. 73, 1222-1227 (1999).
17. 2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J. Biol. Chem. 275, 9572-9580 (2000).
18. Hasuwa, H., Kaseda, K., Einarsdottir, T. #38; Okabe, M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532, 227-230 (2002).
19. 2-adrenergic receptor. J. Biol. Chem. 273, 322-328 (1998).
20. Mason, C. S. et al. Serine and tyrosine phosphorylations, cooperate in Raf-1, but not B-Raf activation. EMBO J. 18, 2137-2148 (1999).
21. AbdAlla, S., Lother, H. #38; Quitterer, U. AT1-receptor heterodimers show enhanced G-proteln activation and altered receptor sequestration. Nature 407, 94-98 (2000).
22. 1receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nature Med. 7, 1003-1009 (2001).
23. Darman, R. B., #38; Forbush, B. A regulatory locus of phosphorylation in the N terminus of the Na-K-Cl cotransporter, NKCCl. J. Biol. Chem. 277, 37542-37550 (2002).
24. 2receptor antagonist. J. Biol. Chem. 276, 39721-39726 (2001).
25. 2receptor activation regulates myocardial eNOS expression via the calcineurin-NFAT pathway. FASEB J. 17, 283-285 (2003).
26. Wu, J. C., Tsai, R. Y. #38; Chung, T. H. Role of catenins in the development of gap junctions in rat cardiomyocytes. J. Cell. Biochem. 88, 823-835 (2003).
27. Dunigan, C. D., Curran, P. K. #38; Fishman, P. H. Detection of β-adrenergic receptors by radioligand binding. Methods Mol. Biol. 126, 329-343 (2000).